Effects of Gastrostomy on Amyotrophic Lateral Sclerosis

University Hospital, Clermont-Ferrand380 enrolled

Overview

Results about effects of symptomatic treatment on QoL appears conflicting in ALS patients. Moreover no clear effects of gastrotomy have be shown on survival. Prospective study on effect of tube feeding, QoL and survival is performed in 17 teaching hospitals in France (observational study)

Following data have been recorded each three months: QoL (MOS-SF 36 and ALSAQ), bodily mass index, testing and ALS-FRS scale, functional respiratory measures, impedance analysis, and the time for tube feeding procedure, the conditions of the acceptance and side-effects of gastrotomy

Study Type

OBSERVATIONAL

Enrollment

380

Conditions

Amyotrophic Lateral Sclerosis

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * patients \> 18 years-old * ALS certain or probable * vital capacity (respiratory) \> 70 % * under riluzole Exclusion Criteria: * ALS in family * other conditions affected survival and QoL * cognitive impairment

Locations (1)

Clermont-Ferrand University Hospital

Clermont-Ferrand, France

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.